About: IndoVac

An Entity of Type: vaccine, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

IndoVac is a recombinant protein subunit COVID-19 vaccine, developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine in Houston, Texas. It is the world's first officially halal certified COVID-19 vaccine, but the most popular existing vaccines had already been widely endorsed as Halal by various Islamic groups. The vaccine was officially launched by President Joko Widodo on 13 October 2022.

Property	Value
dbo:abstract	IndoVac is a recombinant protein subunit COVID-19 vaccine, developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine in Houston, Texas. It is the world's first officially halal certified COVID-19 vaccine, but the most popular existing vaccines had already been widely endorsed as Halal by various Islamic groups. The vaccine was officially launched by President Joko Widodo on 13 October 2022. (en)
dbo:alternativeName	IndoVac (en)
dbo:thumbnail	wiki-commons:Special:FilePath/IndoVac.svg?width=300
dbo:wikiPageID	72002120 (xsd:integer)
dbo:wikiPageLength	6902 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1121636258 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Baylor_College_of_Medicine dbr:Bio_Farma dbr:Joko_Widodo dbr:Intramuscular_injection dbr:Coronavirus_spike_protein dbr:Ministry_of_Religious_Affairs_(Indonesia) dbr:Halal dbr:Houston,_Texas dbr:COVID-19_vaccine dbc:Products_introduced_in_2022 dbc:Science_and_technology_in_Indonesia dbr:Severe_acute_respiratory_syndrome_coronavirus_2 dbc:Clinical_trials dbc:Protein_subunit_vaccines dbr:Binding_domain dbr:Indonesia dbr:Recombinant_vaccine dbr:Subunit_vaccine
dbp:routesOfAdministration	dbr:Intramuscular_injection
dbp:target	dbr:Severe_acute_respiratory_syndrome_coronavirus_2
dbp:tradename	IndoVac (en)
dbp:type	vaccine (en)
dbp:vaccineType	protein (en)
dbp:wikiPageUsesTemplate	dbt:Infobox_drug dbt:Portal_bar dbt:Reflist dbt:Short_description dbt:Use_dmy_dates dbt:COVID-19_pandemic dbt:COVID-19_pandemic_sidebar dbt:Vaccines dbt:COVID-19_pandemic_in_Indonesia
dcterms:subject	dbc:Products_introduced_in_2022 dbc:Science_and_technology_in_Indonesia dbc:Clinical_trials dbc:Protein_subunit_vaccines
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Vaccine dbo:Drug
rdfs:comment	IndoVac is a recombinant protein subunit COVID-19 vaccine, developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine in Houston, Texas. It is the world's first officially halal certified COVID-19 vaccine, but the most popular existing vaccines had already been widely endorsed as Halal by various Islamic groups. The vaccine was officially launched by President Joko Widodo on 13 October 2022. (en)
rdfs:label	IndoVac (en)
owl:sameAs	wikidata:IndoVac https://global.dbpedia.org/id/GqQw7
prov:wasDerivedFrom	wikipedia-en:IndoVac?oldid=1121636258&ns=0
foaf:depiction	wiki-commons:Special:FilePath/IndoVac.svg
foaf:isPrimaryTopicOf	wikipedia-en:IndoVac
is dbo:wikiPageWikiLink of	dbr:List_of_COVID-19_vaccine_authorizations dbr:Timeline_of_the_COVID-19_pandemic_in_Indonesia_(2022) dbr:COVID-19_vaccination_in_Indonesia dbr:COVID-19_vaccine dbr:COVID-19_vaccine_clinical_research
is foaf:primaryTopic of	wikipedia-en:IndoVac